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Abstract This report describes a versatile and robust
microreactor for bioactive proteins physically immobilized
on a polyether sulfone filter. The potential of the reactor is
illustrated with glucose oxidase immobilized on a filter with
a cut-off value of 30 kDa. A flow-injection system was
used to deliver the reactants and the device was linked on-
line to an electrochemical detector. The microreactor was
used for on-line preparation of apoglucose oxidase in strong
acid and its subsequent reactivation with flavin adenine
dinucleotide. In addition we describe a miniaturized version
of the microreactor used to assess several characteristics of
femtomole to attomole amounts of glucose oxidase. A low
negative potential over the electrodes was used when
ferrocene was the mediator in combination with horseradish
peroxidase, ensuring the absence of oxidation of electro-
active compounds in biological fluids. A low backpressure
at very low flow rates is an advantage, which increases the
sensitivity. A variety of further applications of the micro-
reactor are suggested.
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Introduction
Conventionally, characterizing enzyme properties in terms
of kinetics, conversion rate, and substrate specificity
requires substantial amounts of pure enzyme. We aim to
develop a versatile and robust microreactor to monitor on-
line the activity of small amounts of enzymes, and that can
be used under harsh conditions if required, for instance, to
prepare modified forms of glucose oxidase (GOx) in which
the flavin adenine dinucleotide (FAD) cofactor has been
replaced by artificial flavins. GOx uses β-D-(+)-glucose
with high specificity as substrate, converting it to glucono-
lactone and H2O2. Preparation of apoGOx with low residual
activity requires partial unfolding of the protein under
strongly acidic conditions followed by removal of the flavin
by size-exclusion chromatography [1]. The activity of the
enzyme can be restored by applying a solution of FAD or
FAD analogues [1–4].
Enzyme reactors can be created by covalent immobili-
zation [5, 6]. Another option is to co-polymerise the
enzyme in a flow system, trapping the enzyme in a polymer
matrix [7, 8]. With these approaches assessment of enzyme
properties, inhibitor screening [7], or conversion rates of
stereoselective or enantiomeric substrates [9, 10] have been
reported. Although convenient, covalent attachment and co-
polymerisation require substantial amounts of protein to
obtain a good response [11]. Upon immobilization, enzyme
characteristics are often altered and enzyme activity may be
lost. Especially when rare or expensive enzymes have to be
used, it would be beneficial to have a system that uses far
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easy to handle.
We propose a device where the enzyme is confined in a
small space on top of one filter or between two filters and
continuously perfused. The device, based on our previously
described biosensor technique [12], is robust, easy to handle,
and loss of activity and consumption of enzyme are kept to a
minimum. With this device we were able to prepare apoGOx
on-line by retaining GOx on a single polyether sulfone (PES)
filter using acid treatment. Restoration of the enzyme activity
was achieved in the same system using a solution of FAD.
Furthermore, we were able to miniaturize the microreactor,
using less enzyme, and increase the sensitivity of the system
using a combination of ferrocene and horseradish peroxidase
(HRP) as a mediator for electrochemical detection.
Experimental
Materials
GOx from Aspergillus niger (EC 1.1.3.4, grade 1) and
horseradish peroxidase (HRP; EC 1.11.1.7, grade 1) were
obtained from Roche (Almere, The Netherlands). Ferrocene
carbolic acid was from Lancaster Chemicals (Lancaster
Synthetics UK, Morecambe, Lancs, UK). Other chemicals
were of pro analysis quality and purchased from Merck
(Amsterdam, The Netherlands). Double quartz-distilled
water was used for all aqueous solutions. Before and after
acid treatment, the running buffer (a) of the microreactor
was 0.15 mol L
−1 sodium phosphate, pH 7.0, containing
1m m o lL
−1 NaCl and 0.1% Kathon GC (Rohm and Haas,
Croydon, Surrey, UK). Glucose solution (50 mmol L
−1)
prepared in running buffer was left to stand for several hours
to reach mutarotational equilibrium. For electrochemical
detection of GOx in combination with HRP, the running
buffer (b) also contained 0.5 mmol L
−1 ferrocene carbolic acid.
Design of the microreactors
The overall design of the microreactors is shown in Fig. 1.
They were micro machined from Delrin by the instrumental
workshop of Groningen University. For preparation of
apoGOx and reconstitution of GOx activity, a microreactor
as described in Ref. [12] was used. In contrast to the original
device, only one PES filter with a cut-off value of 30 kDa
(Sartorius,Göttingen,Germany)andpunchedtoa diameterof
13 mm, was used. Performance studies were done with our
miniaturized design. The dimensions of the miniaturized
microreactor were: outer length 3 cm, outer diameter 1.5 cm.
A PES membrane filter was punched to a diameter of 4 mm
and placed in the microreactor (effective diameter 3 mm,
effective volume 1 μL) and connected between the injection
valve and the detector withfused-silica tubing (FST) (150 μm
OD, 50 μm ID) (Polymicro Technologies, Phoenix, AZ,
USA) pinched off in Teflon tubing 1/16 inch OD and 170 μm
ID (Aurora Borealis Control, Schoonebeek, The Netherlands)
with use of finger-tight fittings, to avoid high dead volumes.
Set-up of the system
Theperfusatesofthemicroreactorwereintroducedintoaflow-
injection system and monitored electrochemically (VT-03
electrochemical flow cell and Decade Digital Electrochemical
Amperometric Detector; Antec Leyden, Zoeterwoude, The
Netherlands), essentially as previously described [13–15]. For
the preparation of apoGOx and subsequent reconstitution of
the holoenzyme a voltage of +0.5 V was applied between the
working and reference electrodes.
GOx/HRP activity monitoring
For flows >1 μLm i n
−1, a LC10ADvp solvent-delivery pump
(Shimadzu Corporation, Kyoto, Japan) was used; for flows
<1 μLm i n
−1 a Harvard 22-syringe pump (Harvard Appara-
tus, Holliston, MA, USA) was used. A voltage of −150 mV
was applied between the working (glassy carbon) and
reference (Ag/AgCl) electrodes. The injection valve (Vici
Cheminert C4, Valco Instruments, Houston, TX, USA) was
equipped with a 20 nL internal loop; injection cycles were
Fig. 1 Schematic design of the reaction compartment of the micro-
reactor. (a) sketch; (b) schematic diagram. Shown here is the
microreactor with one PES ultrafilter which is then connected to the
flow system using FST and finger-tight fittings. The mesh screen is
used to support the ultrafilter
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which also thermostatically controlled the reaction tempera-
ture at 37°C. The current was registered using a flatbed
recorder type BD41 (Kipp & Zonen, Delft, The Netherlands)
and/or the signal was integrated using Chromeleon Software
(Dionex Corporation, Sunnyvale, CA, USA) on a PC using
an RS232 interface. After the filter was installed in the
system, it was left to equilibrate to a flow of 50 nL min
−1.
Glucose solution injection was sequenced to load/inject 2/
3 min (cycle time 5 min) and repeated until a stable baseline
was obtained.
Preparation of apoGOx and restoration of the enzyme activity
Preparation ofapoGOx wasessentially the same asdescribed in
Ref. [16], with a solution of 0.1 mol L
−1 glycine, 0.1 mol L
−1
NaCl, and 0.1 mol L
−1 HCl, pH 1.5 mixed with glycerol to a
final concentration of glycerol of 30% (v/v), cooled in ice.
This solution was applied to the GOx containing reactor. In
detail, a 10 μL solution of 100 mg mL
−1 GOx (625 μmol L
−1)
w a sp i p e t t e do nt ot h em i c r o r e a c t o r ’s PES filter, which was
thus loaded with 6.25 nmol. After stabilisation of the signal,
the initial enzyme activity was determined (=100%). The
reactor was detached from the detector. The detached reactor
was cooled in ice, and perfused with the cooled acidic
glycerol solution at a rate of 25 μLm i n
−1 for 15 min. After
application of running buffer (a) until the effluent was pH 7,
the reactor was taken out of the flow system, re-attached to the
detector cell, and the residual activity of the apoGOx was
measured in buffer system (a) with a flow of 25 μLm i n
−1.
After the reactor was released from the flow system, ca
150 μL of an FAD solution (3.4 mmol L
−1) in 0.15 mol L
−1
sodium phosphate, pH 7.0, at room temperature, was
applied manually during ca 15 min, except for time-
dependent tests. Afterwards, the reactor was re-attached to
the detector cell and the restored activity of the holoenzyme
was measured as described above.
Determination of several characteristics of the miniaturized
enzyme reactor
Increasing amounts of GOx in running buffer (b) (range
625 amol to 625 pmol) were injected into the system,
providing the amount of GOx retained on the membrane.
After equilibration, a sequence of load/inject of the glucose
solution was applied. Subsequently, a solution of HRP in
running buffer (b) was injected into the system providing
0.68 pmol (30 ng) of HRP. After equilibration the sequence of
load/inject of glucose was repeated. The efficiency of
conversionattheelectrodewascalculatedaccordingtoEq.(1):
%conversion ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2p ðÞ
p
hs100%
IcnF
ð1Þ
where h = peak height (pA), σ = peak width at 60.7% (s), I =
injection volume (μL), c = concentration (μmol L
−1), n =
number of electrons, F = 96485 (Faraday’sc o n s t a n t ,C
mol
−1)a n d√(2π)hσ is peak area (C)
In Eq. (1) the charge that is transferred to the electrode
(area under the curve) is related to the real charge that is
available in the reaction, e.g. the concentration of the
substrate, the number of electrons involved, and Faraday’s
constant.
Results
Preparation of apoGOx and restoration of the enzyme
activity
We followed the response to glucose, the residual enzyme
activity of apoGOx after acid treatment, and restoration of
the enzyme activity after application of a solution of FAD.
After acid treatment, negligible activity of apoGOx was
observed. Application of the FAD solution restored the
enzyme activity. The time dependency of enzyme activity
restoration is shown in Fig. 2, composed of individual data
from five apoGOx preparations. This time dependency of
the reactivation is in accordance with Eq. (2).
ft ðÞ¼1   exp  kt ðÞ ð 2Þ
where k = 0.035 min
−1 and t is the reaction time (min).
Approximately 80% of the enzyme activity was restored
within 60 min, which is above average compared to other
procedures [1, 2].
Fig. 2 Restoration of apoGOx activity: circles, observed relative
reactivation with FAD; solid line, fitting according to the equation f(t)=
1 − exp(−0.035t)
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Several properties of the system were investigated. These
included backpressure of the reactor at various protein
loads, its stability and reproducibility, the efficiency at the
electrode, system sensitivity, and ease of handling. The
relationship of backpressure to the flow and the amount of
protein retained on the filter are depicted in Figs. 3a and 3b.
The level of the backpressure is acceptable with these flows
and these amounts of protein. The stability and reproduc-
ibility of the system, as tested with 625 fmol GOx on a
series of glucose injections, showed an intra-assay standard
deviation of less than 3%. The efficiency of the reaction is
inversely proportional to the amount of protein on the filter.
The sensitivity of the set-up was determined by retaining various amounts of GOx, ranging from 62.5 amol to
625 pmol on the ultrafilter, and testing the response. A
measurable and reproducible response was obtained, even
with the lowest amounts of enzyme tested (Table 1). One
load of enzyme in the microreactor can be used at least 10
times and the system can be regenerated simply by
replacing the filter and injection of a fresh aliquot of
protein solution.
Conclusions
The low perfusion rate microreactor is suitable for the new
application described here—preparation of minute amounts
of apoGOx and reconstitution of enzyme activity with a
solution of FAD. In comparison to the conventional
preparation of apoGOx using size-exclusion chromatogra-
phy [1, 2, 16], this device requires neither complicated
handling nor expensive materials and equipment. The
enzyme is simply retained on the PES ultrafilter.
A scale-up of the microreactor can easily be performed,
allowing the preparation of larger amounts of apoGOx to be
used, for example, in studies with modified FAD [2–4]o r
as the basis of a biosensor with which a wide variety of
analytes can be detected [1]. The combination with
immunological principles allows the analysis of small
molecules when no specific enzyme is available, combining
molecular recognition with enzyme enhancement of the
signal. The sensitivity is improved even more by using
electrochemical detection.
Low perfusion rate microreactors may facilitate the study
of enzymatic properties and modifications, including sub-
strate inhibition, competitive and non-competitive inhibi-
tion, and allosteric activation. Because of the mild fixation
conditions,theymayenable investigationofreceptor activity
also. An advantage of the microreactor presented here is the
small amount of protein required, thus allowing the use of
expensive and rare enzymes. Applications using related
devices, e.g. Refs. [7, 10, 17] usually require micrograms to
Fig. 3 System backpressure. (a) Backpressure in relation to the flow
at various protein loadings: diamonds,0μg; squares,1 3μg; triangles,
24 μg; circles,3 9μg; stars,6 1μg GOx. (b) Backpressure in relation
to the amount of protein retained on the filter at various flow rates:
circles 1 μL min
−1; squares,5μL min
−1; triangles,1 0μL min
−1;
diamonds,2 5μL min
−1
Table 1 Measured detector signal and relative conversion of glucose
in relation to the amount of enzyme retained on the filter in the
miniaturized microreactor. Indicated are the amounts of GOx (in fmol)
on the PES filter and the signals of the detector (in nA) indicating the
amount of converted glucose, calculated as described in the method
section
Protein (GOx) on the filter (fmol) Signal (nA) Conversion (%)
0.0625 0.016 0.04
0.625 0.028 0.006
6.25 0.051 0.001
625 0.53 0.0001
625000 2.4 0.0000006
2032 Anal Bioanal Chem (2007) 389:2029–2033milligrams of protein. Glucose sensors using glucose
oxidase or glucose dehydrogenase have also been devel-
oped for clinical use. One example of such an application
uses a volume of 300 nL blood for glucose measurements
in diabetics [18]. Such reactors still use larger volumes as
compared to the 20 nL we used here. Although we used
electrochemical detection, other modes of detection includ-
ing capillary electrophoresis, fluorescence, or chemilumi-
nescence, are possible. In addition, with the current interest
in proteomics, applications can be found where minute
amounts of protein can be digested reproducibly and
analysed directly by LC–MS–MS [19–21].
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